Navigation Links
Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
Date:8/19/2007

Management to Make Two Presentations on the Topic of Drug Repurposing and

Indian Clinical Trial Strategy

MORRISTOWN, N.J., Aug. 16 /PRNewswire/ -- Vicus Therapeutics, Inc., an oncology-focused, clinical-stage biopharmaceutical company, announced today that Chief Executive Officer, John Maki, and Chief Scientific Officer, Frederic Young, Ph.D., will each present at the 234th American Chemical Society National Meeting on Sunday, August 19, 2007. The Meeting is being held at the Boston Convention & Exhibition Center in Boston, MA.

Dr. Young will present "Hypothesis-driven Drug Repurposing Based on a Novel Systems Biology Approach," including a discussion of Vicus' complexity theory-based drug repurposing approach in creating a pipeline of product candidates for the treatment of important unmet medical needs. The Company's approach can be applied to the discovery of product candidates for any indication, including cancer cachexia, a metabolic disorder, mucositis, a wound healing disorder, and cancer fatigue, a CNS disorder. The specific application of this method will be discussed in the context of the Company's lead compound, VT-122. Dr. Young's presentation is scheduled for 11:45 a.m.

Mr. Maki's presentation, entitled "Synergistic Advantages of Drug Repurposing and Clinical Trial Off-shoring in India", will include a discussion of the unique synergistic advantages of drug re-profiling and off- shoring, as well as an overview of the steps necessary to realize such advantages. Specifically, Mr. Maki will provide highlights from the Company's ongoing Phase 2 clinical trial of VT-122 for cancer cachexia, now being conducted in the U.S. and India. In addition, he will review recent changes by the Drug Controller General of India (DCGI, the Indian FDA-regulatory equivalent), Indian clinical research infrastructure, and the acceptance of Indian data by the U.S. Food & Drug Administration (FDA) that is currently driving the expl
'/>"/>

SOURCE Vicus Therapeutics

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 Report ... study showing you trends, R&D and predicted revenues ... kinase inhibitors? Now get the latest analysis for ... trends, results, opportunities and revenue forecasts. Visiongain,s ... using protein kinase inhibition and related technology. There ...
(Date:9/23/2014)... BURLINGTON, Mass. , Sept. 23, 2014 ... in pricing and reimbursement (P&R) decision criteria ... along with expert insights into each country, ... messaging across different markets.  Global market access ... very specific market access requirements and challenges—and ...
(Date:9/23/2014)... 2014 Research and Markets  has announced the ... report to their offering. Diabetes is a ... Over 382 million people are estimated to be currently suffering ... 592 million by 2035. With a very high prevalence, ... and India , an increasing proportion ...
Breaking Medicine Technology:Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Va., July 8, 2011 The Amerigroup Foundation recently ... the Rx Partnership to benefit the Rockbridge Area Free ... organization that works to provide uninsured Virginians with access ... broker to access and distribute free bulk prescription medications ...
... /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" ... of premium branded Traditional Chinese Medicine ("TCM") consumer ... attending and presenting at the upcoming 2011 Global ... at the Intercontinental Hotel (888 Howard Street) in ...
Cached Medicine Technology:Amerigroup Foundation Presents Grant to Rx Partnership 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 3
(Date:9/23/2014)... The inaugural single day event in ... New Otani Tokyo Gardens in Tokyo. Clinical data scientists will ... validation. , The second single day event in China ... in Shanghai. The clinical data scientists attending this event will ... and listings, which display data collected in clinical studies and ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 "The primary purpose ... control," said an inventor from Sacramento, Ca.. "Call lights are ... or left hanging on the IV pole out of the ... the nurse call device whenever they need it, I created ... effectively position the nurse call device within easy reach. The ...
(Date:9/23/2014)... 2014 From first-hand experience, Matthew O'Farrell ... and how it can be treated. , A medically ... in 2006. His platoon sustained multiple attacks resulting in ... diagnosed with combat-related PTSD and honorably discharged from the ... I had distanced myself from my friends and family,” ...
(Date:9/23/2014)... HealthDay Reporter TUESDAY, Sept. 23, 2014 (HealthDay ... providing better care, not more care, ... A new report suggests that,s the direction the ... IMS Institute for Healthcare Informatics in Parsippany, N.J., identifies 10 ... delivery of health care and use of medicines over the ...
(Date:9/23/2014)... What information do patients need ... Forum (NQF) released a report ( http://bit.ly/1DwekE9 ), ... infographic ( http://bit.ly/1tX3lzA ) resulting from an in-depth ... patients define affordability, and what information and changes ... possible healthcare at the lowest possible cost. ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Report Identifies Game Changers for U.S. Health Care 2Health News:Report Identifies Game Changers for U.S. Health Care 3Health News:Finding Affordable Care: Asking the Right Question is Key 2
... consumption dropped, study found , FRIDAY, June 18 (HealthDay ... may reduce consumption and help lower levels of obesity ... suggests. , Researchers examined what happened during a time ... in Boston increased the price of regular soft drinks ...
... , ... Life sell an extensive range of vitamins supplements and nutritional supplements by top manufacturers ... ... Established in 1999, Vitamins for Life (vitaminsforlife.co.uk) supplies practitioner-grade nutritional supplements that ...
... 2010: Systemic Lupus Erythematosus (SLE) patients from Brazil ... that their rheumatic conditions negatively affect their emotional ... today at EULAR 2010, the Annual Congress of ... Furthermore, findings of the French study specifically revealed ...
... The effects of Systemic Lupus Erythematosus (SLE) may differ ... results of a new study presented today at EULAR ... Rheumatism in Rome, Italy. In particular, the study reinforced ... European subpopulations. Results from a Europe-wide study, involving ...
... Kids Bento ... , ... 18, 2010 -- School’s about to start and so is the mad morning scramble of ... kids’ bento boxes , from Laptop Lunches. They’re ideal for packing fun, wholesome, ...
... ... 360 Degree Guarantee and provide consumers with coverage that extends past the original manufacturer labor ... standard warranty. , ... 18, 2010 -- Treadmill Doctor has announced the introduction of their new 360 ...
Cached Medicine News:Health News:People May Skip Soft Drinks Rather Than Pay More 2Health News:Natural Health Online Retailer VitaminsForLife.co.uk Expands Inventory to Meet UK Demands 2Health News:Natural Health Online Retailer VitaminsForLife.co.uk Expands Inventory to Meet UK Demands 3Health News:Sex lives of patients are negatively affected by rheumatoid arthritis and SLE 2Health News:Sex lives of patients are negatively affected by rheumatoid arthritis and SLE 3Health News:Kids' Lunchboxes Go Bento for Easy Back to School Lunch Making, Thanks to Laptop Lunches 2Health News:Treadmill Doctor 360 Degree Guarantee Extended Service Plans 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: